Publikationen von Tiago F. Outeiro
Alle Typen
Zeitschriftenartikel (132)
Zeitschriftenartikel
40, S. 168 - 181 (2017)
Cell reprogramming: Therapeutic potential and the promise of rejuvenation for the aging brain. Ageing Research Reviews
Zeitschriftenartikel
4, 128 (2016)
The effects of the novel A53E alpha-synuclein mutation on its oligomerization and aggregation. Acta Neuropathologica Communications
Zeitschriftenartikel
6, 36798 (2016)
Glycation potentiates neurodegeneration in models of Huntington's disease. Scientific Reports
Zeitschriftenartikel
113 (42), S. E6506 - E6515 (2016)
Environmental and genetic factors support the dissociation between α-synuclein aggregation and toxicity. Proceedings of the National Academy of Sciences of the United States of America
Zeitschriftenartikel
434, S. 238 - 249 (2016)
Distinct roles of N-acetyl and 5-methoxy groups in the antiproliferative and neuroprotective effects of melatonin. Molecular and Cellular Endocrinology
Zeitschriftenartikel
6, 31493 (2016)
The caffeine-binding adenosine A2A receptor induces age-like HPA-axis dysfunction by targeting glucocorticoid receptor function. Scientific Reports
Zeitschriftenartikel
25 (14), S. 2959 - 2971 (2016)
A familial ATP13A2 mutation enhances alpha-synuclein aggregation and promotes cell death. Human Molecular Genetics
Zeitschriftenartikel
12 (6), e1006098 (2016)
C-terminal tyrosine residue modifications modulate the protective phosphorylation of Serine 129 of α-synuclein in a yeast model of Parkinson's disease. PLoS Genetics
Zeitschriftenartikel
31 (6), S. 782 - 790 (2016)
Glycation in Parkinson's disease and Alzheimer's disease. Movement Disorders
Zeitschriftenartikel
12, e1005995 (2016)
shRNA-based screen identifiers endocytic recycling pathway components that act as genetic modifiers of alpha-synuclein aggregation, secretion and toxicity. PLoS Genetics
Zeitschriftenartikel
25 (2), S. 275 - 290 (2016)
Yeast reveals similar molecular mechanisms underlying alpha- and beta-synuclein toxicity. Human Molecular Genetics
Zeitschriftenartikel
6, e1994 (2015)
Elevated α-synuclein caused by SNCA gene triplication impairs neuronal differentiation and maturation in Parkinson's patient-derived induced pluripotent stem cells. Cell Death and Disease Buchkapitel (3)
Buchkapitel
Doxycycline Therapeutic Approach in Parkinson’s Disease and L-DOPA-Induced Dyskinesia. In: Handbook of Neurotoxicity, S. 1539 - 1559 (Hg. Kostrzewa, R. M.). Springer, Cham (2022)
Buchkapitel
Sirtuins in brain and neurodegenerative disease. In: Introductory review on sirtuins in biology, aging, and aging disease, S. 175 - 195 (Hg. Guarente, L.) (2018)
Buchkapitel
Epigenetics in Parkinson's disease. In: Neuroepigenomics in aging and disease (Hg. Delgado Morales, R.) (2017)
Editorial (4)
Editorial
168 (8), S. 1421 - 1683 (2024)
Aging and neurodegeneration: From molecular mechanisms to therapeutic interventions. Journal of Neurochemistry
Editorial
15, 1399709 (2024)
One health care in psychiatric and neurological diseases. Frontiers in Psychiatry
Editorial
17, 1216902 (2023)
Editorial: Personalized care in neurological diseases. Frontiers in Human Neuroscience
Editorial
10 (3), S. 295 - 296 (2018)
SIRT2 in age-related neurodegenerative disorders. Aging Preprint (1)
Preprint
A novel alpha-synuclein G14R missense variant is associated with atypical neuropathological features. medRxiv (2025)